The Ancillary Cannabis Index, which is dollar-denominated and based upon the prices of the U.S. listing for each member, is rebalanced monthly, with each member weighted equally at that time. The index includes companies that provide goods or services to those companies that grow, process or sell cannabis products, including those derived from industrial hemp. Companies must file with the SEC or the securities regulator in the country of their primary listing.

Since the initial launch on 3/31/21, each stock had been required to have an average daily trading value in excess of $500,000 in the U.S. Stocks included must trade at a minimum of $0.50. Effective with the 10/31/21 rebalancing, the minimum daily trading value was increased to $1 million. Effective with the 7/31/22 rebalancing, we lowered it back to $500,000. Companies with primary listings in other countries must have a U.S. listing in order to be included. The company must generate at least $1 million in quarterly revenue from its ancillary operations.

The update as of 10/31/24 was based upon data from 10/29, which resulted in no changes.